<?xml version="1.0" encoding="UTF-8"?><ONIXDOISerialArticleWorkRegistrationMessage xmlns="http://www.editeur.org/onix/DOIMetadata/2.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.editeur.org/onix/DOIMetadata/2.0 http://www.medra.org/schema/onix/DOIMetadata/2.0/ONIX_DOIMetadata_2.0.xsd"><Header>
	    <FromCompany>Verduci Editore</FromCompany>
	    <FromPerson>Sabrina Verduci</FromPerson>
	    <FromEmail>redazione.journals@verduci.it</FromEmail>
	    <ToCompany>mEDRA</ToCompany>
	    <SentDate>20240228</SentDate>
	</Header><DOISerialArticleWork>
		    <NotificationType>06</NotificationType>
		    <DOI>10.61012/JIM_20242_462</DOI>
		    <DOIWebsiteLink>https://jim.simmesn.org/?p=462</DOIWebsiteLink>
		    <RegistrantName>Verduci Editore</RegistrantName>
		    <RegistrationAuthority>mEDRA</RegistrationAuthority>
		    <SerialPublication>
		        <SerialWork>
		            <Title>
		                <TitleType>01</TitleType>
		                <TitleText>Journal of Innate Metabolism</TitleText>
		            </Title>
		            <Publisher>
		                <PublishingRole>01</PublishingRole>
		                <PublisherName>Verduci Editore</PublisherName>
		            </Publisher>
		            <CountryOfPublication>IT</CountryOfPublication>
		        </SerialWork><SerialVersion>
			            <ProductIdentifier>
			                <ProductIDType>07</ProductIDType>
							<IDValue>0000-0000</IDValue>
						</ProductIdentifier>
			            <ProductForm>JB</ProductForm>
			        </SerialVersion></SerialPublication>
		    <JournalIssue>
		        <JournalVolumeNumber>1</JournalVolumeNumber><JournalIssueNumber>1</JournalIssueNumber><JournalIssueDesignation>February 2024</JournalIssueDesignation>
		        <JournalIssueDate>
		            <DateFormat>01</DateFormat>
		            <Date>202402</Date>
		        </JournalIssueDate>
		    </JournalIssue>
		    <ContentItem>
		        <SequenceNumber>1</SequenceNumber>
		        <Title language="eng">
		            <TitleType>01</TitleType>
		            <TitleText>Newborn screening in Italy: it is time for a deep reflection</TitleText>
		        </Title><Contributor>
		                <SequenceNumber>1</SequenceNumber>
		                <ContributorRole>A01</ContributorRole>
		                <NamesBeforeKey>A.</NamesBeforeKey>
		                <KeyNames>Pession</KeyNames>
					</Contributor><Language>
		            <LanguageRole>01</LanguageRole>
		            <LanguageCode>eng</LanguageCode>
		        </Language><OtherText>
			            <TextTypeCode>01</TextTypeCode>
			            <Text language="eng">Newborn screening (NBS) is currently the most challenging topic for the Italian Society for the Study of Hereditary Metabolic Diseases and Newborn Screening (SIMMESN). Many problematic aspects are relevant according to the different components involved in the process; we have chosen those that are particularly critical and need to be shared. For this purpose, we have selected some keywords that require careful consideration and thought. They represent the main starting points toward the quality assurance and review of delivered services, i.e., health technology assessment, within this successful preventive public healthcare program.</Text>
			        </OtherText><PublicationDate>202402</PublicationDate>
		        <CopyrightStatement>
		            <CopyrightYear>2024</CopyrightYear>
		            <CopyrightOwner>
		                <PersonName>A. Pession</PersonName>
		            </CopyrightOwner>
		        </CopyrightStatement>
		    </ContentItem>
		</DOISerialArticleWork></ONIXDOISerialArticleWorkRegistrationMessage>